Westmont, Ill.-based Stella Mental Health has launched Stella Newton, its second Massachusetts location, expanding access to interventional psychiatry care in the Greater Boston area.
The Newton clinic offers Spravato therapy, intravenous ketamine infusions, deep transcranial magnetic stimulation, accelerated TMS and psychiatric medication management, according to a Feb. 17 news release. The organization said the expansion builds on the success of its Brookline location and reflects its growing presence in the Boston region.
In addition, the mental health provider said Boston-based psychiatrist Brian Boyle MD, chief psychiatry officer of Stella’s Massachusetts clinical programs, was selected by Johnson & Johnson as a 2026 Bureau Speaker for Spravato (esketamine) nasal spray. The designation is reserved for a limited number of physicians with expertise in treating treatment-resistant depression.
Dr. Boyle will provide peer-to-peer education and share clinical insights on treatment options for depression as part of the speaker bureau role, according to the release.
Stella Mental Health operates more than 20 locations nationwide, including five locations throughout Utah and more than 10 certified Dual Sympathetic Reset SGB partner sites.
